Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Kimberly-Clark
KMB
$36.6B
| $61.6M | 0.06% |
618,176
-50,149
| -8% | -$5M |
|
277
Morgan Stanley
MS
$330B
| $61.4M | 0.06% |
1,981,237
-508,160
| -20% | -$15.1M |
|
|
WBA
278
DELISTED
Walgreens Boots Alliance
WBA
| $61.3M | 0.06% |
1,075,867
-632,354
| -37% | -$36.8M |
|
279
Best Buy
BBY
$18.5B
| $60.8M | 0.06% |
1,560,238
+131,767
| +9% | +$5.41M |
|
280
Teva Pharmaceuticals
TEVA
$41.2B
| $60.7M | 0.06% |
1,516,461
+333,728
| +28% | +$13.1M |
|
|
WFT
281
DELISTED
Weatherford International plc
WFT
| $60.6M | 0.06% |
+4,041,066
| New | +$64.2M |
|
282
McKesson
MCK
$101B
| $60.5M | 0.06% |
375,845
+97,143
| +35% | +$14.9M |
|
283
PUT
Texas Instruments
TXN
$255B
| $60.3M | 0.06% |
1,401,700
+330,600
| +31% | +$13.8M |
|
284
Delta Air Lines
DAL
$58.3B
| $59.7M | 0.06% |
2,213,015
+685,497
| +45% | +$18.4M |
|
285
Williams Companies
WMB
$86.7B
| $59.1M | 0.06% |
1,554,722
+53,078
| +4% | +$1.91M |
|
286
CALL
Boeing
BA
$175B
| $59M | 0.06% |
434,000
+282,400
| +186% | +$36.7M |
|
287
CALL
Las Vegas Sands
LVS
$32.3B
| $58.9M | 0.06% |
755,200
-243,100
| -24% | -$17.5M |
|
288
Macerich
MAC
$7.22B
| $58.9M | 0.06% |
1,015,118
+415,028
| +69% | +$24.1M |
|
289
Medtronic
MDT
$110B
| $58.9M | 0.06% |
1,032,927
+82,069
| +9% | +$4.65M |
|
|
ESRX
290
DELISTED
Express Scripts Holding Company
ESRX
| $58.9M | 0.06% |
840,778
-380,027
| -31% | -$24.8M |
|
|
MON
291
DELISTED
Monsanto Co
MON
| $58.2M | 0.06% |
501,633
+53,411
| +12% | +$5.83M |
|
292
Deere & Co
DE
$162B
| $57.9M | 0.06% |
636,785
+101,052
| +19% | +$8.55M |
|
293
Dominion Energy
D
$61.3B
| $57.6M | 0.06% |
900,725
-78,445
| -8% | -$5.05M |
|
294
CALL
iShares US Real Estate ETF
IYR
$4.69B
| $57.6M | 0.06% |
914,600
-492,600
| -35% | -$31.7M |
|
295
Phillips 66
PSX
$84.4B
| $56.8M | 0.06% |
738,251
-9,805
| -1% | -$654K |
|
296
CALL
Walmart Inc
WMT
$884B
| $56.6M | 0.06% |
2,175,600
+1,024,200
| +89% | +$26.4M |
|
297
CALL
Altria Group
MO
$113B
| $55.8M | 0.06% |
1,469,100
-401,200
| -21% | -$14.8M |
|
298
Colgate-Palmolive
CL
$73.3B
| $55.5M | 0.06% |
854,000
+114,754
| +16% | +$7.34M |
|
299
CALL
Tesla
TSLA
$1.22T
| $55.5M | 0.06% |
5,547,000
+655,500
| +13% | +$6.69M |
|
300
TJX Companies
TJX
$176B
| $55.4M | 0.06% |
1,759,048
+321,596
| +22% | +$9.74M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.